TAKTIC: A prospective, multicenter, uncontrolled, phase IB/II study of LY2780301 (LY) in combination with weekly paclitaxel (wP) in HER2-negative locally advanced (LA) or metastatic breast cancer (MBC) patients.

Affiliation auteurs!!!! Error affiliation !!!!
TitreTAKTIC: A prospective, multicenter, uncontrolled, phase IB/II study of LY2780301 (LY) in combination with weekly paclitaxel (wP) in HER2-negative locally advanced (LA) or metastatic breast cancer (MBC) patients.
Type de publicationJournal Article
Year of Publication2019
AuteursVicier C, Isambert N, Dalenc F, Campone M, Levy C, Rezai K, Provansal M, Adelaide J, Garnier S, Guille A, Chaffanet M, Popovici C, Charafe-Jauffret E, Pakradouni J, Autret A, Goncalves A
JournalJOURNAL OF CLINICAL ONCOLOGY
Volume37
Date PublishedMAY 20
Type of ArticleMeeting Abstract
ISSN0732-183X
DOI10.1200/JCO.2019.37.15_suppl.1091